Taub Rebecca sold MDGL
December 10, 2025 · Form 4 insider transaction
Taub Rebecca sold 4,410 shares of Madrigal Pharmaceuticals, Inc. at $551.85 per share, a transaction worth $2.43M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,410
Price
$551.85
Total value
$2.43M
InsiderTaub Rebecca
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 10, 2025
Filing dateDecember 12, 2025
Shares owned after469,215
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $551.39 to $552.38, inclusive.